These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3820275)

  • 1. Preparation and immunogenicity of a bivalent cell-surface protein-polysaccharide conjugate of Vibrio cholerae.
    Kabir S
    J Med Microbiol; 1987 Feb; 23(1):9-18. PubMed ID: 3820275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Composition and immunochemical properties of the cell surface proteins of Vibrio cholerae.
    Kabir S
    J Gen Microbiol; 1986 Aug; 132(8):2235-42. PubMed ID: 3794649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serological properties of the cell surface proteins of Vibrio cholerae.
    Kabir S
    J Gen Microbiol; 1983 Jul; 129(7):2199-206. PubMed ID: 6415227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.
    Villeneuve S; Boutonnier A; Mulard LA; Fournier JM
    Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2477-2484. PubMed ID: 10517600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterisation of monoclonal antibodies to outer-membrane-protein antigens of Vibrio cholerae O1.
    Kabir S
    J Med Microbiol; 1991 Mar; 34(3):167-73. PubMed ID: 1901361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immune response to the 18-kDa outer-membrane antigen of Vibrio cholerae.
    Sciortino CV
    J Med Microbiol; 1993 Aug; 39(2):135-40. PubMed ID: 8345508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of an engineered bivalent vaccine strain consisting of Vibrio cholerae CT-B and LPS-O antigens.
    Yu X; Ma Q
    Chin J Biotechnol; 1994; 10(4):225-32. PubMed ID: 7780018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic analysis of Vibrio cholerate O1 by crossed immunoelectrophoresis.
    Kabir S
    Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):361-72. PubMed ID: 2929189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen.
    Paulovicová E; Machová E; Hostacká A; Bystrický S
    Clin Exp Immunol; 2006 Jun; 144(3):521-7. PubMed ID: 16734622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.
    Levinson KJ; Giffen SR; Pauly MH; Kim DH; Bohorov O; Bohorova N; Whaley KJ; Zeitlin L; Mantis NJ
    J Immunol Methods; 2015 Jul; 422():111-7. PubMed ID: 25865265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.
    Boutonnier A; Villeneuve S; Nato F; Dassy B; Fournier JM
    Infect Immun; 2001 May; 69(5):3488-93. PubMed ID: 11292781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and strain differentiation of Vibrio cholerae by using polyclonal antibodies against outer membrane proteins.
    Martínez-Govea A; Ambrosio J; Gutiérrez-Cogco L; Flisser A
    Clin Diagn Lab Immunol; 2001 Jul; 8(4):768-71. PubMed ID: 11427424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chemical and heat inactivation on the antigenicity and immunogenicity of Vibrio cholerae.
    Cryz SJ; Fürer E; Germanier R
    Infect Immun; 1982 Oct; 38(1):21-6. PubMed ID: 7141690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition and immunochemical properties of outer membrane proteins of Vibrio cholerae.
    Kabir S
    J Bacteriol; 1980 Oct; 144(1):382-9. PubMed ID: 7419491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes.
    Ebrahimizadeh W; Mousavi Gargari S; Rajabibazl M; Safaee Ardekani L; Zare H; Bakherad H
    Appl Microbiol Biotechnol; 2013 May; 97(10):4457-66. PubMed ID: 23135228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme-linked immunoassays for antibodies against Vibrio cholerae.
    Cooper GN; McNab CE; Jackson GD; Walker P
    Aust J Exp Biol Med Sci; 1983 Dec; 61 ( Pt 6)():713-25. PubMed ID: 6426450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of enteric-coated tablets as a whole cell inactivated vaccine candidate against Vibrio cholerae.
    Fernández S; Año G; Castaño J; Pino Y; Uribarri E; Riverón LA; Cedré B; Valmaseda T; Falero G; Pérez JL; Infante JF; García LG; Solís RL; Sierra G; Talavera A
    Travel Med Infect Dis; 2013; 11(2):103-9. PubMed ID: 23492079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.